Brain Canada FR

Our directory of funded grants

181 result(s) found

The Experimental Imaging Centre: a Local Brain Canada Platform for Preclinical MR Neuroimaging

Project Overview

The Experimental Imaging Centre Brain Canada Platform provides state of the art pre-clinical imaging to the neuroscience research community. The core technology is a 9.4T MRI with associated animal care and physiological monitoring aimed at rat and mouse models of human neuropathology. MRI has evolv…

See researchers on this project
Principal Investigator:
  • Jeff Dunn, University of Calgary
Team Members:
  • Ursula Tuor, University of Calgary
  • Prasanth Chelikani, University of Calgary
  • Michael Esser, Alberta Children's Hospital Research Institute
  • Bruce Pike, Montreal Neurological Hospital and Institute
  • Garnette Sutherland, University of Calgary
  • Peter Stys, University of Calgary
  • G. Campbell Teskey, University of Calgary
  • V. Wee Yong, University of Calgary
  • Stephen Robbins, University of Calgary

The feasibility of hyperpolarized 13C-Pyruvate MRI for monitoring patients with intracranial metastasis

Project Overview

Surgery and radiation are standard treatments for cancer that has spread to the brain. Recent research has revealed that cancer cells with high levels of the chemical lactate are aggressive and resist radiation therapy. Dr Charles Cunningham will study whether an enhanced imaging method that can det…

See researchers on this project
Principal Investigator:
  • Charles Cunningham, Sunnybrook Research Institute

The Frontier Trial – Field Randomization of NA-1 Treatment In Early Responders

Project Overview

Stroke is a life threatening emergency caused by blocked arteries that affects 45,000 Canadians a year. Each hour a stroke is left untreated means brain cells are dying. The only emergency treatment we have is a clot busting agent that can re-open blocked arteries if given within 3-4.5 hours of the …

See researchers on this project
Principal Investigator:
  • Jim Christenson, University of British Columbia
Team Members:
  • Oscar Benavente, University of British Columbia
  • William Dick, B.C. Emergency Health Services

The interplay of DNA regulatory elements and epigenetics in Alzheimer’s disease

Project Overview

Alzheimer’s disease (AD) is a severely disabling illness with biological causes that are not well understood. Abnormalities in gene function impacts brain activities and could cause AD. Enhancers are elements in the DNA code that enable the complex expression of genes. Epigenetic marks control enh…

See researchers on this project
Principal Investigator:
  • Viviane Labrie, Centre for Addiction and Mental Health